|
Volumn 6, Issue 2, 2002, Pages 117-121
|
Prospective phase II study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome;Prospektive Phase-II-Studie zur neoadjuvanten Radiochemotherapie fortgeschrittener, operabler Mundhöhlenkarzinome. 3-Jahres-Ergebnisse.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CLINICAL TRIAL;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MORTALITY;
MOUTH TUMOR;
MULTIMODALITY CANCER THERAPY;
OROPHARYNX TUMOR;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
ADULT;
AGED;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MOUTH NEOPLASMS;
NEOADJUVANT THERAPY;
NEOPLASM STAGING;
OROPHARYNGEAL NEOPLASMS;
RADIOTHERAPY, ADJUVANT;
SURVIVAL RATE;
MLCS;
MLOWN;
|
EID: 0036518536
PISSN: 14329417
EISSN: None
Source Type: Journal
DOI: 10.1007/s10006-002-0370-y Document Type: Article |
Times cited : (22)
|
References (0)
|